MedTrace Logo

Accuracy of Continuous Glucose Monitoring in Patients With Diabetes. A Prospective Observational Study

NCT06297850 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-05-04

No results posted yet for this study

Summary

The goal of this observational study is to investigate the accuracy of the continuous glucose monitoring (CGM) compared to standard point-of-care (POC) blood glucose measurements in patients with diabetes in patients who during their hospital admission can experience circulatory impairment.

The main questions it aims to answer are:

• Do CGM measurements have a decreased accuracy compared to standard blood glucose measurements in periods with circulatory impairment?

Participants will be asked to wear a blinded CGM device (Dexcom G7, Dexcom Inc.) during their stay in the hospital but will receive standard care of their diabetes. The CGM device will be worn for up to 10 days.

Conditions

  • Diabetes Mellitus
  • Dysglycemia
  • Perioperative Complication
  • Circulatory; Complications

Interventions

DEVICE

Dexcom G7 Continuous Glucose Monitoring (CGM) System (G7)

A CGM device placed on the posterior aspect of the upper arm in which a sensor placed in the skin registers glucose values. Via Bluetooth, these readings are sent to a receiver near the patient every 5 minutes. The CGM system can alert when deviating glucose levels, but will for this observational study be blinding to patients and clinical staff. Thus, the patients' diabetic care will rely on standard practice.

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Steno Diabetes Center Copenhagen

    collaborator OTHER

  • Zealand University Hospital

    collaborator OTHER

  • University Hospital Bispebjerg and Frederiksberg

    lead OTHER

Principal Investigators

  • Eske K Aasvang, MD, DmSci · Dept. of Anaesthesiology, Centre for Cancer and Organ Diseases, Rigshospitalet, Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2025-06-01
Completion
2026-01-01
FDA Device
Yes

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06297850 on ClinicalTrials.gov